http://orcid.org/0000-0001-5854-1502
Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nadav Liam Modlin, Michael Creed, Maria Sarang, Carolina Maggio, James J Rucker & Victoria Williamson. (2024) Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. Neuropsychiatric Disease and Treatment 20, pages 109-135.
Read now
Read now
James W. B. Elsey, Vivi Anna F. Wuestman & Anouk Fieten. (2023) User perceptions of long-term costs and benefits of MDMA use: findings from a large online sample. Drugs: Education, Prevention and Policy 0:0, pages 1-13.
Read now
Read now
Carla Mendes Soares, Ângela Leite & Marta Pinto. (2023) Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives. Journal of Psychoactive Drugs 55:2, pages 159-169.
Read now
Read now
Marieke J. van Gelderen, Mirjam J. Nijdam, G. Elsemieke Dubbink, Marieke Sleijpen & Eric Vermetten. (2020) Perceived treatment processes and effects of interactive motion-assisted exposure therapy for veterans with treatment-resistant posttraumatic stress disorder: a mixed methods study. European Journal of Psychotraumatology 11:1.
Read now
Read now
Richard E. Doblin, Merete Christiansen, Lisa Jerome & Brad Burge. (2019) The Past and Future of Psychedelic Science: An Introduction to This Issue. Journal of Psychoactive Drugs 51:2, pages 93-97.
Read now
Read now
Articles from other publishers (27)
Yuan Yao, Dan Guo, Tang-Sheng Lu, Fang-Lin Liu, Shi-Hao Huang, Meng-Qi Diao, Su-Xia Li, Xiu-Jun Zhang, Thomas R Kosten, Jie Shi, Yan-Ping Bao, Lin Lu & Ying Han. (2024) Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research 335, pages 115886.
Crossref
Crossref
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow & Rachel Yehuda. (2024) The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 22:4, pages 636-735.
Crossref
Crossref
Mesud Sarmanlu, Kim P.C. Kuypers, Patrick Vizeli & Timo L. Kvamme. (2024) MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 128, pages 110843.
Crossref
Crossref
Sascha B. Thal, Paris Baker, Jonathon Marinis, Michelle Wieberneit, Jason M. Sharbanee, Raimundo Bruno, Petra M. Skeffington & Stephen J. Bright. (2023) Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review. Clinical Psychology & Psychotherapy 31:1.
Crossref
Crossref
Samuli Kangaslampi & Josjan Zijlmans. (2023) MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations. European Child & Adolescent Psychiatry.
Crossref
Crossref
M. Kati Lear, Sarah M. Smith, Brian Pilecki, Chris S. Stauffer & Jason B. Luoma. (2023) Social anxiety and MDMA-assisted therapy investigation: a novel clinical trial protocol. Frontiers in Psychiatry 14.
Crossref
Crossref
Macha Godes, Jasper Lucas & Eric Vermetten. (2023) Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions. Frontiers in Psychiatry 14.
Crossref
Crossref
Carina Winkler Sørensen, Charlotte Sonne, Maria Sacha, Maria Kristiansen, Sigrid Zeuthen Hannemose, Dan J. Stein & Jessica Carlsson. (2023) Potential advantages of combining randomized controlled trials with qualitative research in mood and anxiety disorders - A systematic review. Journal of Affective Disorders 325, pages 701-712.
Crossref
Crossref
Nadiia Omelchenko & Anton Kurapov. (2023) Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change. Bulletin of Taras Shevchenko National University of Kyiv. Psychology:1 (17), pages 56-64.
Crossref
Crossref
Tor-Morten Kvam, Ivar W. Goksøyr, Lowan H. Stewart, Dimitris Repantis, Jan Ivar Røssberg & Ole A. Andreassen. (2022) Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”. Frontiers in Psychiatry 13.
Crossref
Crossref
Joost J Breeksema, Bouwe W Kuin, Jeanine Kamphuis, Wim van den Brink, Eric Vermetten & Robert A Schoevers. (2022) Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology 36:10, pages 1100-1117.
Crossref
Crossref
William Barone, Michiko Mitsunaga-Whitten, Lia Osunfunláyò Blaustein, Phillip Perl, Marisa Swank & Thomas Cody Swift. (2022) Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness. Frontiers in Psychiatry 13.
Crossref
Crossref
Ryan L. Henner, Matcheri S. Keshavan & Kevin P. Hill. (2022) Review of otential sychedelic reatments for PTSD. Journal of the Neurological Sciences 439, pages 120302.
Crossref
Crossref
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, Kim P. C. Kuypers & Carmela Mento. (2022) Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions. Frontiers in Psychology 13.
Crossref
Crossref
Jason B. Luoma, Ben Shahar, M. Kati Lear, Brian Pilecki & Anne Wagner. (2021) Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships. Human Psychopharmacology: Clinical and Experimental 37:3.
Crossref
Crossref
Emilija Glavonic, Milos Mitic & Miroslav Adzic. (2022) Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction. Journal of Neuroscience Research 100:4, pages 947-969.
Crossref
Crossref
Terence H. W. Ching, Monnica T. Williams, Sara J. Reed, Michael D. Kisicki, Julie B. Wang, Berra Yazar-Klosinski, Amy Emerson & Rick Doblin. (2022) MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial. Journal of Humanistic Psychology, pages 002216782210769.
Crossref
Crossref
Amanda J. Khan, Ellen Bradley, Aoife O’Donovan & Joshua Woolley. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
319
332
.
João Castelhano, Gisela Lima, Marta Teixeira, Carla Soares, Marta Pais & Miguel Castelo-Branco. (2021) The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies. Frontiers in Pharmacology 12.
Crossref
Crossref
Jason Luoma & M. Kati Lear. (2021) MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder. Frontiers in Psychiatry 12.
Crossref
Crossref
Courtney Hutchison & Sara Bressi. (2020) Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments. Clinical Social Work Journal 49:3, pages 356-367.
Crossref
Crossref
Sarah Tedesco, Ganeya Gajaram, Shahzad Chida, Arham Ahmad, Meghan Pentak, Marina Kelada, Layth Lewis, Deepa Krishnan, Carolyn Tran, Oladipo T Soetan, Lawrance T Mukona & Ayodeji Jolayemi. (2021) The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis. Cureus.
Crossref
Crossref
Joost J. Breeksema, Alistair R. Niemeijer, Erwin Krediet, Eric Vermetten & Robert A. Schoevers. (2020) Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. CNS Drugs 34:9, pages 925-946.
Crossref
Crossref
Lisa Jerome, Allison A. Feduccia, Julie B. Wang, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C. Mithoefer & Rick Doblin. (2020) Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Psychopharmacology 237:8, pages 2485-2497.
Crossref
Crossref
Richard J. Zeifman & Anne C. Wagner. (2020) Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder. Journal of Contextual Behavioral Science 15, pages 1-11.
Crossref
Crossref
Katrin H. Preller & Franz X. Vollenweider. (2019) Modulation of Social Cognition via Hallucinogens and “Entactogens”. Frontiers in Psychiatry 10.
Crossref
Crossref
Milena Jadrijević-Mladar Takač, Joao Daniel Casimiro Magina & Tin Takač. (2019) Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study. Acta Pharmaceutica 69:4, pages 563-584.
Crossref
Crossref